I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer

NARecruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2021

Study Completion Date

November 30, 2025

Conditions
Differentiated Thyroid Carcinoma
Interventions
RADIATION

Radioiodine I-131

Radioiodine will be used for ablation therapy, dosimetry and posttherapeutic whole body scan, as well as low dose I-131 imaging.

RADIATION

I-124

I-124 will be used for imaging to assess uptake inside and outside of thyroid bed, using PET/CT whole body scanning, followed by I-131 therapy as necessary as per protocol.

Trial Locations (2)

45122

RECRUITING

Clinic of Nuclear Medicine, University Clinic Essen, Essen

97080

RECRUITING

University Clinic Würzburg, Würzburg

All Listed Sponsors
collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

lead

University of Wuerzburg

OTHER